| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines
|
Heijtink, R.A.
|
|
2000
|
18 |
15 |
p. 1531-1538
8 p.
|
article
|
| 2 |
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
|
Nitayaphan, Sorachai
|
|
2000
|
18 |
15 |
p. 1448-1455
8 p.
|
article
|
| 3 |
Cattle immune responses to tetanus toxoid elicited by recombinant S. typhimurium vaccines or tetanus toxoid in alum or Freund's adjuvant
|
Villarreal-Ramos, Bernardo
|
|
2000
|
18 |
15 |
p. 1515-1521
7 p.
|
article
|
| 4 |
Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8–10-year-old children
|
Duval, B.
|
|
2000
|
18 |
15 |
p. 1467-1472
6 p.
|
article
|
| 5 |
European perspectives in the control of infectious diseases, Malta, 16 April 1999
|
Osterhaus, A.D.M.E.
|
|
2000
|
18 |
15 |
p. 1431-1432
2 p.
|
article
|
| 6 |
Gelatin-containing diphtheria–tetanus–pertussis (DTP) vaccine causes sensitization to gelatin in the recipients
|
Kumagai, Takuji
|
|
2000
|
18 |
15 |
p. 1555-1561
7 p.
|
article
|
| 7 |
Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes
|
Hasan, U.A
|
|
2000
|
18 |
15 |
p. 1506-1514
9 p.
|
article
|
| 8 |
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age
|
de Kleijn, Ester D
|
|
2000
|
18 |
15 |
p. 1456-1466
11 p.
|
article
|
| 9 |
Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein
|
Djavani, Mahmoud
|
|
2000
|
18 |
15 |
p. 1543-1554
12 p.
|
article
|
| 10 |
Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver
|
Rogers, James V
|
|
2000
|
18 |
15 |
p. 1522-1530
9 p.
|
article
|
| 11 |
Patent report
|
|
|
2000
|
18 |
15 |
p. 1562-
1 p.
|
article
|
| 12 |
Patent report
|
|
|
2000
|
18 |
15 |
p. 1563-
1 p.
|
article
|
| 13 |
Patent report
|
|
|
2000
|
18 |
15 |
p. 1562-
1 p.
|
article
|
| 14 |
Patent report
|
|
|
2000
|
18 |
15 |
p. 1562-1563
2 p.
|
article
|
| 15 |
Patent report
|
|
|
2000
|
18 |
15 |
p. 1562-
1 p.
|
article
|
| 16 |
Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity
|
Dilts, D.A.
|
|
2000
|
18 |
15 |
p. 1473-1484
12 p.
|
article
|
| 17 |
Potential of DNA vaccines delivered by influenza virosomes
|
Cusi, M.G
|
|
2000
|
18 |
15 |
p. 1435-
1 p.
|
article
|
| 18 |
The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly
|
Gessner, Bradford D.
|
|
2000
|
18 |
15 |
p. 1485-1494
10 p.
|
article
|
| 19 |
Typhoid fever vaccines
|
Engels, Eric A
|
|
2000
|
18 |
15 |
p. 1433-1434
2 p.
|
article
|
| 20 |
Vaccine nomenclature: the three-letter code
|
Maurer, Wolfgang
|
|
2000
|
18 |
15 |
p. 1539-1542
4 p.
|
article
|
| 21 |
Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers
|
Baras, Benoı̂t
|
|
2000
|
18 |
15 |
p. 1495-1505
11 p.
|
article
|
| 22 |
Vaccines in historic evolution and perspective: a narrative of vaccine discoveries
|
Hilleman, Maurice R
|
|
2000
|
18 |
15 |
p. 1436-1447
12 p.
|
article
|
Journal description